New Delhi [India], September 29: Heart disease is no longer just a concern for older adults—it is increasingly affecting young people in their 20s, 30s, and 40s. Sedentary lifestyles, stress, … Read More
Hyderabad (Telangana) [India], September 27: Apollo Hospitals, one of Asia’s largest and most trusted healthcare providers, has signed a strategic agreement with the Ministry of Interior, Republic of Iraq, to … Read More
New Delhi [India], September 27: In the heart of Anand, a city known for Amul and its role in India’s White Revolution, a young boy was learning lessons that would … Read More
New Delhi [India], September 27: In a significant development for India’s animal health sector, veterinary vaccine manufacturers have come together to announce the formation of the Veterinary Vaccine India Manufacturers … Read More
Hyderabad (Telangana) [India], September 25: Nearly 50% of Indian women aged between 35 and 49 years are now classified as overweight or obese, according to a recent study reported by … Read More
Hyderabad (Telangana) [India], September 25: Fertility preservation is no longer a subject confined to medical textbooks and oncology wards—it is now part of mainstream conversations among India’s urban, career-driven women. … Read More
Hetero Healthcare and Enzene launched Perzea, India’s most affordable Pertuzumab biosimilar Hyderabad (Telangana) [India], September 25: Hetero Healthcare Limited, in strategic collaboration with Enzene Biosciences, has launched Perzea, India’s most affordable Pertuzumab … Read More
New Delhi [India], September 25: With breast cancer on the rise and 1 in 8 Indian women at risk, a landmark initiative blends knowledge, self-advocacy, and risk assessment to transform … Read More
Hyderabad (Telangana) [India], September 25: In a landmark initiative to expand affordable breast cancer treatment in India, Hetero Healthcare Limited has announced the launch of Perzea, its most cost-effective biosimilar of Pertuzumab. … Read More
Hyderabad (Telangana) [India], September 25: Reinforcing the Government of India’s mission to provide equitable healthcare, Hetero Healthcare Limited, in partnership with Enzene Biosciences, has launched Perzea, its most affordable biosimilar Pertuzumab for HER2-positive … Read More
